Donald E. Ingber
Donald E. Ingber, M.D., Ph.D.
Founding Director, Core Faculty member &
Biomimetic Microsystems Platform Leader
Wyss Institute for Biologically Inspired Engineering at Harvard University
Judah Folkman Professor of Vascular Biology
Harvard Medical School
Boston Children's Hospital
Professor of Bioengineering
Harvard John A. Paulson School of Engineering & Applied Sciences
Donald E. Ingber is the Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children's Hospital, and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences. He received his B.A., M.A., M.Phil., M.D. and Ph.D. from Yale University. Dr. Ingber's work has catalyzed the convergence of far-reaching disciplines never before connected, ranging from biology, medicine, engineering, computer science and physics to art, architecture and design. His efforts contributed to the emergence of the field of Biologically Inspired Engineering, and at the Wyss Institute, he oversees a multifaceted mission to identify the mechanisms that living organisms use to self-assemble from molecules and cells, and to apply these design principles to develop advanced materials and devices for healthcare and to improve sustainability. He also leads the Biomimetic Microsystems Platform in which microfabrication techniques from the computer industry are used to build tiny, complex, three-dimensional models of living human organs. These "Organs on Chips" mimic complicated human functions as a way to replace traditional animal-based methods for testing of drugs and establishment of human disease models. In addition, he has made major contributions to understanding cell structure, mechanobiology, tissue engineering, tumor angiogenesis, systems biology, nanobiotechnology, medical devices, and translational medicine. Dr. Ingber has authored more than 400 publications and 100 patents, founded three companies to commercialize his technologies, and has received numerous honors in a broad range of disciplines, including the Holst Medal, Department of Defense Breast Cancer Innovator Award, Pritzker Award from the Biomedical Engineering Society, Rous-Whipple Award from the American Society for Investigative Pathology, Lifetime Achievement Award from the Society of In Vitro Biology, Leading Edge Award from the Society of Toxicology, NC3Rs Award, and 2015 Design of the Year Award. He is also an honorary member of the Society of Toxicology, and member of both the American Institute for Medical and Biological Engineering, and the U.S National Academy of Medicine (formerly Institute of Medicine). His work has been featured by various national and international media organizations, such as BBC, NOVA, CBS, and NPR, and his organs-on-chips technology is in the permanent collection of the Museum of Modern Art (MoMA) in New York City.
In Episode 3 of the Disruptive: Bioinspired Robotics podcast from the Wyss Institute, Don Ingber discusses how his team has developed a device that may radically transform the way sepsis is treated....